Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tuberculous meningitis (TBM) is difficult to diagnose promptly. The utility of the Xpert MTB/RIF test for the diagnosis of TBM remains unclear, and the effect of host- and sample-related factors on test performance is unknown. This study sought to evaluate the sensitivity and specificity of Xpert MTB/RIF for the diagnosis of TBM. METHODS AND FINDINGS: 235 South-African patients with a meningeal-like illness were categorised as having definite (culture or Amplicor PCR positive), probable (anti-TBM treatment initiated but microbiological confirmation lacking), or non-TBM. Xpert MTB/RIF accuracy was evaluated using 1 ml of uncentrifuged and, when available, 3 ml of centrifuged cerebrospinal fluid (CSF). To evaluate the incremental value of MTB/RIF over a clinically based diagnosis, test accuracy was compared to a clinical score (CS) derived using basic clinical and laboratory information. Of 204 evaluable patients (of whom 87% were HIV-infected), 59 had definite TBM, 64 probable TBM, and 81 non-TBM. Overall sensitivity and specificity (95% CI) were 62% (48%-75%) and 95% (87%-99%), respectively. The sensitivity of Xpert MTB/RIF was significantly better than that of smear microscopy (62% versus 12%; p = 0.001) and significantly better than that of the CS (62% versus 30%; p = 0.001; C statistic 85% [79%-92%]). Xpert MTB/RIF sensitivity was higher when centrifuged versus uncentrifuged samples were used (82% [62%-94%] versus 47% [31%-61%]; p = 0.004). The combination of CS and Xpert MTB/RIF (Xpert MTB/RIF performed if CS<8) performed as well as Xpert MTB/RIF alone but with a ∼10% reduction in test usage. This overall pattern of results remained unchanged when the definite and probable TBM groups were combined. Xpert MTB/RIF was not useful in identifying TBM among HIV-uninfected individuals, although the sample was small. There was no evidence of PCR inhibition, and the limit of detection was ∼80 colony forming units per millilitre. Study limitations included a predominantly HIV-infected cohort and the limited number of culture-positive CSF samples. CONCLUSIONS: Xpert MTB/RIF may be a good rule-in test for the diagnosis of TBM in HIV-infected individuals from a tuberculosis-endemic setting, particularly when a centrifuged CSF pellet is used. Further studies are required to confirm these findings in different settings. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“13 studies (839 samples; 10 with .10samples, 159 culture positive) evaluated Xpert in CSF against culture [14-16, 19, 20, 22-25, 27-29, 31].”
From Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis (2014) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 1×
“Our previous work has shown that such cases (Xpert MTB/RIF positive but culture negative) are likely to be true TB positives, and this is corroborated by high specificity obtained in large sputum-based studies where a significant minority of the patients had had previous TB [11].”
ResultHelb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914 · cited 1×
“The Xpert MTB/RIF assay consists of two main components, namely, a Xpert MTB/RIF plastic cartridge (containing the liquid sample processing and PCR buffers, and lyophilized real-time PCR reagents with internal sample processing and PCR probe quality controls) and the automated Xpert MTB/RIF machine (which controls the…”
MethodCentral Nervous System Tuberculosis: Pathogenesis and Clinical Aspects
Rock, R. B., Olin, M., Baker, C. A., Molitor, T. W., & Peterson, P. K. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-07 · Cited by 763 · cited 1×
“These patients frequently require prolonged admission, they have high morbidity rates due to neuro-pathology, and mortality is substantial (,30%), particularly if the diagnosis and follow-on therapy are delayed [5–8].”
BackgroundHIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720 · cited 1×
“Although the incidence of TB is decreasing worldwide, it remains a significant cause of morbidity and mortality in sub-Saharan Africa, where, fuelled by the HIV epidemic, it is out of control [1,2].”
BackgroundThwaites, G., Fisher, M., Hemingway, C., Scott, G., Solomon, T., & Innes, J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.06.011 · Cited by 666 · cited 1×
“culture and/ or Amplicor PCR was positive, probable TBM (treated empirically with anti-TB drugs but not meeting the definite TBM criteria), or non-TBM (alternate diagnosis confirmed and response to therapy documented in the absence of anti-TB treatment) [16,17].”
BackgroundLawn, S. D., & Nicol, M. P. (2011) · Future Microbiology · doi:10.2217/fmb.11.84 · Cited by 486
Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-10 · Cited by 413 · cited 1×
“Published data include only small numbers of microbiologically proven TBM cases (range of 0 to 23) [29–32], often in a case-control design with a non-uniform reference standard, and often CSF-associated data were published as part of a laboratory-based evaluation of extrapulmonary TB samples, usually including samples…”
BackgroundDiagnosis of adult tuberculous meningitis by use of clinical and laboratory features
Thwaites, G., Chau, T., Stepniewska, K., Phu, N., Chuong, L., Sinh, D., White, N., Parry, C., & Farrar, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11318-3 · Cited by 395 · cited 2×
“[35].”
BackgroundPai, M., Flores, L. L., Pai, N., Hubbard, A., Riley, L. W., & Colford, J. M. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00772-2 · Cited by 384 · cited 1×
“PCR (polymerase chain reaction) as a diagnostic test for TBM has a sensitivity of ,50% and a specificity close to 100% [9].”
BackgroundXpert MTB/RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis?
Vadwai, V., Boehme, C., Nabeta, P., Shetty, A., Alland, D., & Rodrigues, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02319-10 · Cited by 357 · cited 1×
“Published data include only small numbers of microbiologically proven TBM cases (range of 0 to 23) [29–32], often in a case-control design with a non-uniform reference standard, and often CSF-associated data were published as part of a laboratory-based evaluation of extrapulmonary TB samples, usually including samples…”
BackgroundTheron, G., Peter, J., van Zyl-Smit, R., Mishra, H., Streicher, E., Murray, S., Dawson, R., Whitelaw, A., Hoelscher, M., Sharma, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0056oc · Cited by 311 · cited 1×
“CT values were correlated with bacterial load (Bactec MGIT 960 time to culture positivity [TTP]), and PCR inhibition was evaluated by comparing the CT value of the internal positive control (IPC; Bacillus globigii) in CSF to that in sputum samples obtained from a previously described reference cohort [13].”
MethodSelf-citationTuberculosis of the central nervous system
Garg, R. K. (1999) · Postgraduate Medical Journal · doi:10.1136/pgmj.75.881.133 · Cited by 306
Improving the Bacteriological Diagnosis of Tuberculous Meningitis
Thwaites, G. E., Chau, T. T. H., & Farrar, J. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.378-379.2004 · Cited by 288 · cited 1×
“, as diagnostic and treatment delay is associated with higher mortality [35–37].”
BackgroundNeurological aspects of tropical disease: Tuberculous meningitis
Thwaites, G. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.3.289 · Cited by 274
Chang, K., Lu, W., Wang, J., Zhang, K., Jia, S., Li, F., Deng, S., & Chen, M. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.02.012 · Cited by 267 · cited 1×
“There are limited data about Xpert MTB/RIF performance in TBM [28].”
MethodAdult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases
Jarvis, J. N., Meintjes, G., Williams, A., Brown, Y., Crede, T., & Harrison, T. S. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-67 · Cited by 266 · cited 1×
“Given the bias of selecting prevalence based on definite-TBM and non-TBM cases only, and given that the approximate prevalence in a hospital-based cohort is closer to 30% [24,25], this strategy would have detected nine patients by CS and a further 17 patients in the remainder by centrifuged Xpert MTB/RIF, i.”
CENTRAL NERVOUS SYSTEM TUBERCULOSIS
Garcia-Monco, J. C. (1999) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70164-x · Cited by 163
Tuberculous meningitis in South African urban adults
Karstaedt, A. (1998) · QJM · doi:10.1093/qjmed/91.11.743 · Cited by 155 · cited 1×
“These patients frequently require prolonged admission, they have high morbidity rates due to neuro-pathology, and mortality is substantial (,30%), particularly if the diagnosis and follow-on therapy are delayed [5–8].”
BackgroundIoannidis, P., Papaventsis, D., Karabela, S., Nikolaou, S., Panagi, M., Raftopoulou, E., Konstantinidou, E., Marinou, I., & Kanavaki, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00718-11 · Cited by 153
Comparison of Two Molecular Methods for Rapid Diagnosis of Extrapulmonary Tuberculosis
Causse, M., Ruiz, P., Gutiérrez-Aroca, J. B., & Casal, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00491-11 · Cited by 145 · cited 2×
“Published data include only small numbers of microbiologically proven TBM cases (range of 0 to 23) [29–32], often in a case-control design with a non-uniform reference standard, and often CSF-associated data were published as part of a laboratory-based evaluation of extrapulmonary TB samples, usually including samples…”
BackgroundResultWelinder-Olsson, C., Dotevall, L., Hogevik, H., Jungnelius, R., Trollfors, B., Wahl, M., & Larsson, P. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01756.x · Cited by 144
Technology for Automated, Rapid, and Quantitative PCR or Reverse Transcription-PCR Clinical Testing
Raja, S., Ching, J., Xi, L., Hughes, S. J., Chang, R., Wong, W., McMillan, W., Gooding, W. E., McCarty, K. S., Chestney, M., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046474 · Cited by 136 · cited 1×
“and rifampicin resistance in a single-use-cartridge hands-free step [18–20].”
BackgroundComparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden
van Zyl-Smit, R. N., Binder, A. B., Meldau, R., Mishra, H. K., Semple, P. L., Theron, G., Peter, J., Whitelaw, A. C., Sharma, S. K., Warren, R. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028815 · Cited by 126 · cited 1×
“This explains the sub-optimal sensitivity of Xpert MTB/RIF compared to culture, where the detection threshold is as low as 1–10 organisms per millilitre [38].”
BackgroundSelf-citationXpert MTB/RIF Assay for Diagnosis of Pleural Tuberculosis
Friedrich, S. O., von Groote-Bidlingmaier, F., & Diacon, A. H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05454-11 · Cited by 126
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay
Blakemore, R., Nabeta, P., Davidow, A. L., Vadwai, V., Tahirli, R., Munsamy, V., Nicol, M., Jones, M., Persing, D. H., Hillemann, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0536oc · Cited by 118 · cited 1×
“[26]).”
Diagnosis of tuberculous meningitis: clinical and laboratory parameters
Bhigjee, A. I., Padayachee, R., Paruk, H., Hallwirth-Pillay, K. D., Marais, S., & Connoly, C. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.07.007 · Cited by 116 · cited 1×
“Given the bias of selecting prevalence based on definite-TBM and non-TBM cases only, and given that the approximate prevalence in a hospital-based cohort is closer to 30% [24,25], this strategy would have detected nine patients by CS and a further 17 patients in the remainder by centrifuged Xpert MTB/RIF, i.”
Tuberculous meningitis in HIV-infected individuals
Vinnard, C., & Macgregor, R. R. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0019-7 · Cited by 96 · cited 1×
“These patients frequently require prolonged admission, they have high morbidity rates due to neuro-pathology, and mortality is substantial (,30%), particularly if the diagnosis and follow-on therapy are delayed [5–8].”
BackgroundSimmons, C. P., Thwaites, G. E., Quyen, N. T. H., Török, M. E., Hoang, D. M., Chau, T. T. H., Phuong, P., Lan, N. T. N., Dung, N. H., Quy, H. T., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.2007 · Cited by 95 · cited 1×
“If patients were unable to give consent and a lumbar puncture was clinically indicated, the Head of the Department of Neurology was approached for consent [15].”
BackgroundEing, B. R., Becker, A., Sohns, A., & Ringelmann, R. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.2023-2029.1998 · Cited by 90 · cited 1×
“Sensitivity was considerably better than in previous studies using commercially available or non-standardised PCR tools [9,32–34].”
ResultPatel, V. B., Singh, R., Connolly, C., Coovadia, Y., Peer, A. K. C., Parag, P., Kasprowicz, V., Zumla, A., Ndung'u, T., & Dheda, K. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1931oc · Cited by 71 · cited 1×
“Using this cut-off, patients were classified into positive and negative, which forms the dichotomous classification of the CS [23].”
MethodSelf-citationSchaaf, H. S., Moll, A. P., & Dheda, K. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.08.019 · Cited by 58 · cited 1×
“and rifampicin resistance in a single-use-cartridge hands-free step [18–20].”
BackgroundSelf-citationTherese, K. L., Jayanthi, U., & Hn, M. (2005) · PubMed · Cited by 48
Pai, M., & Ling, D. I. (2008) · Future Microbiology · doi:10.2217/17460913.3.1.1 · Cited by 37 · cited 1×
“and rifampicin resistance in a single-use-cartridge hands-free step [18–20].”
BackgroundExtrapulmonary tuberculosis in high prevalence of tuberculosis and low prevalence of HIV
Özbay, B., & Uzun, K. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(02)00002-3 · Cited by 33 · cited 1×
“Up to 40% of co-infected patients have extrapulmonary TB, and ,10% of those with extrapulmonary TB have tuberculous meningitis (TBM) [3,4].”
BackgroundBowles, E., Freyee, B., van Ingen, J., Mulder, B., Boeree, M. J., & van Soolingen, D. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0574 · Cited by 33
Jönsson, B., & Ridell, M. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310012244 · Cited by 28 · cited 1×
“Sensitivity was considerably better than in previous studies using commercially available or non-standardised PCR tools [9,32–34].”
ResultRemoval of inhibitors of CSF-PCR to improve diagnosis of herpesviral encephalitis
Ratnamohan, V. M., Cunningham, A. L., & Rawlinson, W. D. (1998) · Journal of Virological Methods · doi:10.1016/s0166-0934(98)00020-2 · Cited by 23 · cited 1×
“In contrast to previous PCR-based studies [40,41], we found that CSF had a minimal inhibitory effect on the PCR reaction when compared to sputum.”
ResultCharacteristics of Xpert MTB/RIF-Negative Patients With Pulmonary Tuberculosis
Theron, G., Peter, J., & Dheda, K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis465 · Cited by 5 · cited 1×
“We did not find a correlation between TTP and Xpert MTB/RIF CT values, as has been shown in sputum [39].”
MethodSelf-citation
Cited by
Dheda, K., Barry, C. E., & Maartens, G. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00151-8 · Cited by 599
Self-citationDenkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
on behalf of the Tuberculous Meningitis International Research Consortium, Wilkinson, R. J., Rohlwink, U., Misra, U. K., van Crevel, R., Mai, N. T. H., Dooley, K. E., Caws, M., Figaji, A., Savic, R., et al. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.120 · Cited by 508
Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis
Chiang, S. S., Khan, F. A., Milstein, M. B., Tolman, A. W., Benedetti, A., Starke, J. R., & Becerra, M. C. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70852-7 · Cited by 316
Bahr, N. C., Nuwagira, E., Evans, E. E., Cresswell, F. V., Bystrom, P. V., Byamukama, A., Bridge, S. C., Bangdiwala, A. S., Meya, D. B., Denkinger, C. M., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30474-7 · Cited by 308
Metadata
- Authors
- Patel, V. B., Theron, G., Lenders, L., Matinyena, B., Connolly, C., Singh, R., Coovadia, Y., Ndung'u, T., & Dheda, K.
- Affiliations
- University of KwaZulu-Natal (ZA)
- University of Cape Town (ZA)
- South African Medical Research Council (ZA)
- National Health Laboratory Service (ZA)
- Corresponding author
- Patel, Vinod B.
- Dheda, Keertan
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-22
- Volume
- 10
- Issue
- 10
- Pages
- e1001536
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC3805498
- OpenAlex
- W2015704537
- Semantic Scholar
- 01fd01a49e444834c91830734d96a1c175d2b813
- Cited by
- 179
- References
- 39
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 17 · 2019: 23 · 2018: 23 · 2017: 19 · 2016: 14 · 2015: 17 · 2014: 23 · 2013: 1
- FWCI
- 18.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Open University of Cape Town (University of Cape Town) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (EU-FP7-)
- National Research Foundation
- Claude Leon Foundation
- Inyuvesi Yakwazulu-Natali
- Victor Daitz Foundation
- National Institutes of Health
- Medical Research Council (EU FP7)
- Fogarty International Center (D43-TW00231, D43TW000231)
- European and Developing Countries Clinical Trials Partnership
- Topics
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- tuberculous meningitis, Xpert MTB/RIF, real-time PCR, diagnostic accuracy, sensitivity and specificity, cerebrospinal fluid, centrifugation, smear microscopy, clinical scoring systems, HIV infection, PCR inhibition, South Africa, rapid molecular diagnostics, cost-effectiveness of testing, smear-negative tuberculosis, smear-positive tuberculosis
- MeSH terms
- Adult, Female, Humans, Male, Prospective Studies, Tuberculosis, Meningeal, Polymerase Chain Reaction, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.